2020
DOI: 10.1016/j.mehy.2020.109782
|View full text |Cite
|
Sign up to set email alerts
|

Purposing Saikosaponins for the treatment of COVID-19

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
27
0
1

Year Published

2020
2020
2025
2025

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(28 citation statements)
references
References 4 publications
0
27
0
1
Order By: Relevance
“…In addition, saikosaponins have great potential in the treatment of COVID-19 through immunomodulatory, anti-inflammatory and antiviral activities. On the one hand, saikossaponins exhibit anti-inflammatory effect by dose-dependently inhibiting the production of several inflammatory mediators which are responsible for the cytokine storm of severe COVID-19 patients, and immunomodulatory effect by inhibiting the proliferation of activated T lymphocytes ( Bahbah et al, 2020 ). On the other hand, it can also directly bind to ACE2 to play the role of anti-SARS-CoV-2 ( Yan Y.-M. et al, 2020 ).…”
Section: Application Of Traditional Chinese Medicine To Prevent and Tmentioning
confidence: 99%
“…In addition, saikosaponins have great potential in the treatment of COVID-19 through immunomodulatory, anti-inflammatory and antiviral activities. On the one hand, saikossaponins exhibit anti-inflammatory effect by dose-dependently inhibiting the production of several inflammatory mediators which are responsible for the cytokine storm of severe COVID-19 patients, and immunomodulatory effect by inhibiting the proliferation of activated T lymphocytes ( Bahbah et al, 2020 ). On the other hand, it can also directly bind to ACE2 to play the role of anti-SARS-CoV-2 ( Yan Y.-M. et al, 2020 ).…”
Section: Application Of Traditional Chinese Medicine To Prevent and Tmentioning
confidence: 99%
“…ACE2 is involved in regulating cardiac function and is also a functional receptor for the coronavirus that causes acute respiratory syndrome (SARS). ACE2 receptors are the largest target of SARS-CoV-2 because they play an important role in the transmission of viruses to alveolar cells [ 13 ]. Inhibition or regulation of ACE2 receptors may potentially be effective in the treatment of COVID-19.…”
Section: Introductionmentioning
confidence: 99%
“…The potency of different saikosaponins against different sets of SARS-CoV-2 binding protein via computational molecular docking simulations were evaluated [ 45 ]. Docking studies were carried out on a Glide module of Schrodinger Maestro 2018-1MM Share Version on NSP15 (PDB ID: 6W01) and Prefusion 2019-nCoV spike glycoprotein (PDB ID: 6VSB) from SARS-CoV-2 [ 46 ]. Saikosaponins U ( 9 ) and V ( 10 ) ( Figure 3 ) showed the best affinity towards both the proteins, based on binding energy and interaction data, suggesting them to be molecule of interest as they mark the desire interaction with NSP15, which is responsible for 2019-nCoV spike glycoprotein and the replication of RNA, which manage the connection with ACE2 [ 47 ].…”
Section: Saikosaponinsmentioning
confidence: 99%
“…Saikosaponins U ( 9 ) and V ( 10 ) ( Figure 3 ) showed the best affinity towards both the proteins, based on binding energy and interaction data, suggesting them to be molecule of interest as they mark the desire interaction with NSP15, which is responsible for 2019-nCoV spike glycoprotein and the replication of RNA, which manage the connection with ACE2 [ 47 ]. Additional results indicate that saikosaponin B2 ( 8 ) has potent anticoronaviral activity and that its mode of action possibly involves interference in the early stage of viral replication, such as absorption and penetration of the virus [ 44 , 45 , 46 ].…”
Section: Saikosaponinsmentioning
confidence: 99%